These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 9585567

  • 1. Caldesmon-actin-tropomyosin contains two types of binding sites for myosin S1.
    Sen A, Chalovich JM.
    Biochemistry; 1998 May 19; 37(20):7526-31. PubMed ID: 9585567
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The inhibitory complex of smooth muscle caldesmon with actin and tropomyosin involves three interacting segments of the C-terminal domain 4.
    Fraser ID, Copeland O, Bing W, Marston SB.
    Biochemistry; 1997 May 06; 36(18):5483-92. PubMed ID: 9154931
    [Abstract] [Full Text] [Related]

  • 5. [C-terminal sites of caldesmon drive ATP hydrolysis cycle by shifting actomyosin itermediates from strong to weak binding of myosin and actin].
    Pronina OE, Copeland O, Marston S, Borovikov IuS.
    Tsitologiia; 2006 May 06; 48(1):9-18. PubMed ID: 16568830
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a caldesmon fragment that competes with myosin-ATP binding to actin.
    Velaz L, Chen YD, Chalovich JM.
    Biophys J; 1993 Aug 06; 65(2):892-8. PubMed ID: 8218912
    [Abstract] [Full Text] [Related]

  • 7. Caldesmon reduces the apparent rate of binding of myosin S1 to actin-tropomyosin.
    Sen A, Chen YD, Yan B, Chalovich JM.
    Biochemistry; 2001 May 15; 40(19):5757-64. PubMed ID: 11341841
    [Abstract] [Full Text] [Related]

  • 8. Influence of ionic strength, actin state, and caldesmon construct size on the number of actin monomers in a caldesmon binding site.
    Fredricksen S, Cai A, Gafurov B, Resetar A, Chalovich JM.
    Biochemistry; 2003 May 27; 42(20):6136-48. PubMed ID: 12755616
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of actin-tropomyosin activation of myosin MgATPase activity by the smooth muscle regulatory protein caldesmon.
    Marston SB, Redwood CS.
    J Biol Chem; 1992 Aug 25; 267(24):16796-800. PubMed ID: 1387396
    [Abstract] [Full Text] [Related]

  • 10. Modulation of actomyosin ATPase by thin filament-associated proteins.
    Chacko S, Miyata H, Horiuchi KY.
    Prog Clin Biol Res; 1987 Aug 25; 245():143-58. PubMed ID: 2960977
    [Abstract] [Full Text] [Related]

  • 11. [Caldesmon and myosin subfragment-1 act differently on the structural state of 1,5-IAEDANS-modified tropomyosin in ghost muscle fibers].
    Borovikov IuS, Novak E, Khoroshev MI, Dabrowska R.
    Biokhimiia; 1990 Jul 25; 55(7):1294-8. PubMed ID: 2223904
    [Abstract] [Full Text] [Related]

  • 12. Caldesmon restricts the movement of both C- and N-termini of tropomyosin on F-actin in ghost fibers during the actomyosin ATPase cycle.
    Kulikova N, Pronina OE, Dabrowska R, Borovikov YS.
    Biochem Biophys Res Commun; 2006 Jun 23; 345(1):280-6. PubMed ID: 16678131
    [Abstract] [Full Text] [Related]

  • 13. Effect of caldesmon on the ATPase activity and the binding of smooth and skeletal myosin subfragments to actin.
    Hemric ME, Chalovich JM.
    J Biol Chem; 1988 Feb 05; 263(4):1878-85. PubMed ID: 2962997
    [Abstract] [Full Text] [Related]

  • 14. Fesselin binds to actin and myosin and inhibits actin-activated ATPase activity.
    Schroeter MM, Chalovich JM.
    J Muscle Res Cell Motil; 2005 Feb 05; 26(4-5):183-9. PubMed ID: 16179973
    [Abstract] [Full Text] [Related]

  • 15. Structure-activity studies of the regulatory interaction of the 10 kilodalton C-terminal fragment of caldesmon with actin and the effect of mutation of caldesmon residues 691-696.
    Huber PA, Gao Y, Fraser ID, Copeland O, EL-Mezgueldi M, Slatter DA, Keane NE, Marston SB, Levine BA.
    Biochemistry; 1998 Feb 24; 37(8):2314-26. PubMed ID: 9485378
    [Abstract] [Full Text] [Related]

  • 16. A mosaic multiple-binding model for the binding of caldesmon and myosin subfragment-1 to actin.
    Chen YD, Chalovich JM.
    Biophys J; 1992 Oct 24; 63(4):1063-70. PubMed ID: 1420925
    [Abstract] [Full Text] [Related]

  • 17. Decavanadate binding to a high affinity site near the myosin catalytic centre inhibits F-actin-stimulated myosin ATPase activity.
    Tiago T, Aureliano M, Gutiérrez-Merino C.
    Biochemistry; 2004 May 11; 43(18):5551-61. PubMed ID: 15122921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.